548results about "Platinum organic compounds" patented technology

Provided are organometallic compounds including a ligand LA ofAlso provided are formulations including these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

The present disclosure includes compounds, compositions, and methods for nucleic acid amplification reactions. In particular, the present disclosure provides compounds, compositions, and methods for viability PCR (vPCR) applications, in which the compounds that selectively bind to nucleic acids from non-viable cells.

Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

The present disclosure provides for an organic electroluminescent device (OLED) including an anode; a cathode; and an emissive layer, disposed between the anode and the cathode. The emissive layer includes a phosphorescent dopant, a first host, and a second host, wherein the first host transports holes, the second host transports electrons, and the first host is fully or partially deuterated. Consumer products that include the OLED are also provided.

The present invention relates to a metal complex having a structure of chemical formula (I). The metal complex is applied to an organic light-emitting device which emits deep red or near-infrared light, and shows a lower driving voltage and higher luminous efficiency, and has greatly prolonged service life. Therefore, the metal complex has the potential of being applied in the field of organic light-emitting devices. Also provided is an organic light-emitting device, including a cathode, an anode, and an organic layer. The organic layer is one or more of a hole injection layer, a hole transport layer, a light-emitting layer, a hole blocking layer, an electron transport layer, and an electron injection layer; and at least one layer in the organic layer contains the compound of structural formula (I).

Provided are an organometallic compound represented by Formula 1, a light-emitting device including the organometallic compound, and an electronic apparatus including the light-emitting device:Each substituent in Formula 1 is the same as described in the specification.

A light-receiving device in which an increase in driving voltage is inhibited is provided. Any of the following light-receiving devices is provided: a light-receiving device that includes a light-receiving layer between a pair of electrodes and in which the light-receiving layer includes an active layer, a buffer layer, and an electron-transport layer, the buffer layer is between the active layer and the electron-transport layer and is in contact with the active layer, and the buffer layer includes an organic compound having an electron-withdrawing group; a light-receiving device that includes a light-receiving layer between a pair of electrodes and in which the light-receiving layer includes an active layer, a buffer layer, and an electron-transport layer, the buffer layer is between the active layer and the electron-transport layer and is in contact with the active layer, and the buffer layer includes a heteroaromatic compound having an electron-withdrawing group.

A compound having a first ligand LA comprising a structure of Formula I,is provided. In Formula I, moiety B is a monocyclic ring or a polycyclic fused ring system; each of X1 to X6 is C or N; Y is a linking group; K is a direct bond or a linking group; each substituent is hydrogen or a General Substituent defined herein; and at least one of the following conditions is true: (1) an RA substituent is joined with an RB substituent to form a ring AB, which may be substituted by one or more RAB substituents; or (2) X5 and X6 are C, and the corresponding two RA substituents are joined to form a cyclic moiety A1, which may be substituted by one or more RA1 substituents; and moiety B is a polycyclic fused ring system. Formulations, OLEDs, and consumer products containing the compound are also provided.

Provided is a compound including a metal complex having a metal M with a coordination number of four with four coordinating atoms, Z1, Z2, Z3, and Z4, coordinated to the metal M. In the compound, each of Z1, Z2, Z3, and Z4 is independently selected from O, S, Se, N, P, C, Si, or B; at least one of Z1, Z2, Z3, or Z4 is S* or Se*, where S* and Se* represent S or Se, respectively, that form a dative bond with M; and the metal M is selected from Pt, Pd, Cu, Ag, Au, or Zn, Formulations, OLEDs, and consumer products containing the compound are also provided.

Compound of Formula I,is provided. In Formula I, rings A, B, C, and D are 5- or 6-membered rings; each of X1-X5, X21-X22, and Z1-Z3 is C or N; each of L1, L2, and L3 is selected from a direct bond or a divalent linker; each of a and b is 0 or 1; Y is O, S, Se, or NRY; W is O, S, NRW, C═RW, or CRWRW′; up to 1 of Z1 to Z3 is N; each R, R′, RA, RB, RC, RD, RY, RW, and RW′ is hydrogen or a substituent. Formulations, OLEDs, and consumer products containing the same are also disclosed.

Provided is a compound including a first ligand LA of Formula IIn Formula I, ring C is a 5- or 6-membered ring; each of X1 to X8 is C or N; one of X1 to X4 is C and is connected to ring C, and one of X1 to X4 is N and is coordinated to a metal M; Y is a divalent linker; K is a direct bond, O, or S; each R′, R″, RA, RB, and RC is hydrogen or a general substituent; at least one of RA or RB comprises an electron-withdrawing group; at least one of RB is a cyclic group; and metal M is selected from Os, Ir, Pd, Pt, Cu, Ag, and Au. Formulations, devices, and consumer products comprising the compound are also disclosed.

The invention relates to the technical field of graded screening, in particular to a graded screening system based on staggered stacked metal ring films and a preparation method and application. An organic ligand and two metal complexes are subjected to interface coordination assembly under the action of silver ions, an ordered staggered stacked metal ring film is constructed, the structure and performance of the metal ring film are precisely regulated and controlled, the metal ring film has a definite molecular sieve component difference, and then precise grading screening of different molecules is achieved. The film has an obvious lattice structure, has good crystalline orderliness, and can ensure the stability and reliability of the screening process. The graded screening system based on the staggered stacked metal ring membranes has excellent interception performance on target molecules, and effective separation of TAC from glucan and leucine can be achieved. The two-stage membrane classification screening strategy can also be popularized to separation and purification of other substances, and good universality and industrial application prospects are achieved.

The invention relates to organic electroluminescent materials and devices. There is provided a compound having a first ligand LA having a structure of Formula I wherein consecutive two of X1 to X8 are C and bonded to the structure of Formula II in Formula I, Part A is a monocyclic or polycyclic fused ring system; each of Z1 to Z2 and X1 to X12 is C or N; each of Y1 and Y2 is a linking group; k is a direct bond or a linking group; each substituent is hydrogen or a universal substituent as defined herein; and LA is coordinated with the metal M. Also provided is a compound having the formula Ir (LA *) x (LB *) y (LC *) z as defined herein. Formulations, OLEDs and consumer products containing these compounds are further provided.

Provided are an organometallic compound, a light-emitting device including the organometallic compound, and an electronic apparatus including the light-emitting device. The light-emitting device includes a first electrode, a second electrode facing the first electrode, and an interlayer disposed between the first electrode and the second electrode. The interlayer includes an emission layer. The emission layer includes a first compound which is the organometallic compound; and a second compound, a third compound, a fourth compound, or any combination thereof. The first compound, the second compound, the third compound, and the fourth compound are different from one another.

The invention discloses a platinum (IV)-pirfenidone compound prodrug, a preparation method and microenvironment remodeling anti-tumor application, and belongs to the field of medical technology and drug synthesis. A series of molecules are characterized by being platinum prodrugs modified by pirfenidone derivatives. The synthesis method sequentially comprises the following steps: oxidizing platinum drugs, modifying hydroxyl groups, and introducing pirfenidone derivatives through esterification reaction. A series of molecules are reduced into Pt (II) drugs at the focus to kill cancer cells, and meanwhile, the released pirfenidone derivative can remodel the tumor microenvironment. The platinum prodrug disclosed by the invention not only has excellent cancer cell killing ability, but also is relatively low in drug resistance and excellent in safety, can trigger immunogenic cell death, and is a brand new chemotherapy-immunotherapy method. A series of molecules are convenient to synthesize, the preparation process is simple, and the amphipathicity is excellent, the anti-cancer capability is excellent, the drug resistance and toxicity are low, and the clinical application prospect is good.

The invention relates to organic electroluminescent materials and devices. An organometallic compound is provided comprising a platinum or palladium atom as a central metal atom coordinated by a tetradentate ligand. Formulations comprising these organometallic compounds are also provided. Further provided are organic light emitting devices (OLED) and related consumer products utilizing these organometallic compounds.

The invention belongs to the technical field of medicine synthesis, and particularly relates to a tetravalent platinum compound as well as a preparation method and application thereof. The invention provides a tetravalent platinum compound. The tetravalent platinum compound has a structure shown as a formula a to a formula d, wherein linker is respectively connected with a Pt-containing mother nucleus and a PARP inhibitor through-O-C = O; the PARP inhibitor comprises a carboxyl-containing structure and a carboxyl-free structure; when the PARP inhibitor contains a carboxyl structure, the linker is when the PARP inhibitor does not contain the carboxyl structure, and the data of the linker as the embodiment shows that the tetravalent platinum compound provided by the invention has good anti-tumor activity and low tumor drug resistance when being used as the PARP inhibitor.

The invention relates to organic electroluminescent materials and devices. There is provided a compound having a first ligand LA comprising a structure of Formula I in which each of moieties A and B is a monocyclic or polycyclic fused ring system; at least one RA or RB has the structure of formula II, wherein the dashed line represents a bond to part A or part B, respectively; the part D is a polycyclic fused ring system; each of Z1 to Z4 and X1 to X5 is C or N; l is a direct bond or a linking group; y is a linking group; each of K1 and K2 is a direct bond or a linking group; and the dashed line of formula I is coordinated with the metal M. Formulations, OLEDs, and consumer products containing the compounds are also provided.

Provided are an organometallic compound represented by Formula 1 and an organic light emitting device including the same. The substituents of Formula 1 are the same as described in the specification. Formula 1

A light-emitting device includes a first electrode, a second electrode opposite to the first electrode, an interlayer between the first electrode and the second electrode, and an organometallic compound represented by Formula 1. In addition, there are provided an electronic apparatus and electronic equipment each including the light-emitting device, and the organometallic compound represented by Formula 1.

The present invention relates to the technical field of organic light-emitting materials, and provides a tetradentate cyclometalated platinum (II) complex based on an oxygen atom linkage and containing phenyl acridine and an application thereof. The tetradentate cyclometalated platinum (II) complex has the structure as represented by general formula (I). (I) The cyclometalated platinum (II) complex in the present invention adopts a tetradentate ligand, is high in rigidity, and can improve the light stability of a light-emitting material. At the same time, the complex molecule can strongly emit light, and therefore can be used as a light-emitting material in an OLED device.

The invention discloses a continuous preparation method of a platinum bulk drug, which comprises the following steps: by taking chloroplatinite as a starting material, in a reaction environment of taking water as a solvent, replacing the starting material with iodized salt to obtain iodoplatinite, and then adding an amine ligand to quickly react to generate an intermediate-cis-diiodo-platinum-amine complex; introducing the solid-liquid mixed system containing the intermediate into a filtering and washing device, filtering and washing, directly discharging the solid into a reaction kettle, adding silver salt and water, reacting completely, and filtering; and concentrating the filtrate to obtain a crude product of the target product, and recrystallizing the crude product to obtain the platinum bulk drug. Or reacting the filtrate with a leaving group (or a salt formed by the leaving group) of the target compound, concentrating, filtering and washing to obtain a crude product of the target product, and recrystallizing the crude product to obtain the platinum bulk drug. The production efficiency and quality consistency of the product can be improved, the process amplification flow is simplified, the production cost and material consumption are reduced, green manufacturing is realized, and the method is an optimal choice for industrial production of platinum bulk drugs.

An OLED is disclosed whose emissive layer has a first host and an emitter, where the emitter is a phosphorescent metal complex or a delayed fluorescent emitter, where EH1T, the T1 triplet energy of the first host, is higher than EET, the T1 triplet energy of the emitter, where EET is at least 2.50 eV, where the LUMO energy of the first host is higher than the HOMO energy of the emitter, where the absolute value of the difference between the HOMO energy of the emitter and the LUMO energy of the first host is ΔE1, where a ≤ ΔE1 - EET ≤ b; and where a ≥ 0.05 eV, and b ≤ 0.60 eV.

The invention relates to the technical field of luminescent materials, in particular to a circularly polarized phosphorescent Pt (II) complex as well as a preparation method and application thereof. The circularly polarized phosphorescent Pt (II) complex has a structure as shown in a formula (R)-I, a formula (S)-I, a formula (R)-II, a formula (S)-II, a formula (R)-III or a formula (S)-III, according to the invention, [2.2] paracyclophane is mainly used as a planar chiral skeleton, and different sites of the planar chiral skeleton are modified to obtain the circularly polarized phosphorescent Pt (II) complex which is stable in chirality and is not easy to racemize. The high-efficiency circularly polarized phosphorescent Pt (II) complex with both luminous quantum yield and circular polarization property is obtained by utilizing the advantages of a four-coordinate plane structure, high exciton utilization rate and adjustable color of the Pt (II) complex, and the high-efficiency circularly polarized phosphorescent Pt (II) complex has great research value on development of circularly polarized chiral materials. .

The application belongs to the technical field of luminescent materials, and particularly relates to a binuclear platinum complex and application thereof. The binuclear platinum complex has the structure shown in formula (1), and when used in an OLED, especially in a blue light emitting region, the binuclear platinum complex exhibits enhanced phosphorescence quantum yield, good luminescence stability, high luminescence efficiency, and is suitable for use as an emitter material in OLED application. The metal platinum complex of the application can obtain an organic electroluminescent device with deep blue phosphorescence and improved luminescence efficiency, and the luminescent device has good thermal stability. The binuclear platinum complex has the advantages of narrow emission spectrum, high stability and high efficiency by adjusting the structure of the ligand around the metal center and the structure of the substituent on the ligand to control the photophysical properties, and has wide application prospects in many fields such as OLED display and lighting.

The invention relates to organic electroluminescent materials and devices. Organometallic compounds comprising one central metal atom and at least one at least bidentate ligand comprising at least two moieties independently being a monocyclic or polycyclic fused ring system wherein each ring of the monocyclic or polycyclic fused ring system is independently a 5-to 10-membered carbocyclic or heterocyclic ring are provided. Formulations comprising these organometallic compounds are also provided. Organic light emitting devices (OLED) and related consumer products utilizing these organometallic compounds are also provided.

A compound having a first ligand LA comprising a structure of Formula I,is provided. In Formula I, each of X1 to X8 is C or N; K is a direct bond or a linker; each RZ, Rα, Rβ, RA, and RB is hydrogen or a General Substituent defined herein; LA is coordinated to a metal M; and at least one of the following statements is true: (1) at least one RA is an electron-withdrawing group other than 4-fluorophenyl and no two RB substituents are joined or fused to form a benzofuran moiety with the furan fused to ring B; or (2) two RA are joined to form a 5-membered or 6-membered monocycle fused to ring A, and RZ and an RB substituent are joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Provided herein are polysiloxane matrices and biocompatible membranes thereof for the detection of oxygen. In particular, oxygen-sensitive fluorophores embedded within the polysiloxane matrices are utilized to detect oxygen consumption rates in living cells.